GL1X · GenesisL1 explorer

MolNFT v1 · #102692 · protein

Crystal structure of the kinase domain of BRUTON'S tyrosine kinase with GDC0834

4OTF · Tyrosine-protein kinase btk: “Crystal structure of the kinase domain of BRUTON'S tyrosine kinase with GDC0834”. X-ray diffraction, 2 ligands (2VL, SO4), 2 pockets (best druggability 0.66). MolNFT v1 #102692 on GenesisL1: 3D…

PDB
4OTF
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
2VL, SO4
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein26343% helix, 17% strandQ06187

Ligands and binding sites

  • 2VL · N-{3-[6-({4-[(2R)-1,4-dimethyl-3-oxopiperazin-2-yl]phenyl}amino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl]-2-methylphenyl }-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13430.660.80452VL
2740.390.7813empty

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 4OTF · Crystal structure of the kinase domain of Bruton's Tyrosine kinase with GDC0834 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.